Verus Capital Partners’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.3K | Sell |
16,600
-200
| -1% | -$618 | ﹤0.01% | 416 |
|
|
2025
Q1 | $58.6K | Sell |
16,800
-2,550
| -13% | -$8.9K | 0.01% | 404 |
|
|
2024
Q4 | $63.3K | Sell |
19,350
-7,550
| -28% | -$24.7K | 0.01% | 392 |
|
|
2024
Q3 | $104K | Sell |
26,900
-14,635
| -35% | -$56.3K | 0.01% | 380 |
|
|
2024
Q2 | $128K | Sell |
41,535
-400
| -1% | -$1.24K | 0.01% | 368 |
|
|
2024
Q1 | $108K | Buy |
41,935
+9,800
| +30% | +$25.3K | 0.01% | 344 |
|
|
2023
Q4 | $80.3K | Sell |
32,135
-1,000
| -3% | -$2.5K | 0.01% | 317 |
|
|
2023
Q3 | $67.3K | Sell |
33,135
-500
| -1% | -$1.02K | 0.01% | 300 |
|
|
2023
Q2 | $77.4K | Sell |
33,635
-1,000
| -3% | -$2.3K | 0.01% | 288 |
|
|
2023
Q1 | $105K | Buy |
34,635
+7,310
| +27% | +$22.1K | 0.02% | 281 |
|
|
2022
Q4 | $63.7K | Sell |
27,325
-375
| -1% | -$874 | 0.01% | 261 |
|
|
2022
Q3 | $53K | Buy |
+27,700
| New | +$53K | 0.01% | 268 |
|
|
2022
Q2 | – | Sell |
-28,600
| Closed | -$72K | – | 289 |
|
|
2022
Q1 | $72K | Buy |
+28,600
| New | +$72K | 0.01% | 318 |
|